Sponsor:
Boehringer Ingelheim
Code:
NCT06531824
Conditions
Kidney Disease, Chronic
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
BI 690517
Placebo matching BI 690517
Empagliflozin
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-08-27. This information was provided to ClinicalTrials.gov by Boehringer Ingelheim on 2025-08-22.